Back to compounds

COMPOUND PROFILE / PROTEINS & BIOLOGICS

Insulin Detemir.

Research draft

Insulin detemir is a long-acting insulin analogue.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Insulin detemir is a long-acting insulin analogue.

CLASSIFICATIONProteins & biologics
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

Acylation and albumin binding contribute to prolonged action.

Human research

Human trials support diabetes treatment; market availability has changed in some regions.

Preclinical & other research

Pharmacology studies examine the mechanism of protraction.

Safety & unknowns

Severe hypoglycaemia remains possible; duration and substitution decisions are clinically important.

Regulatory status

Historical authorisation and current supply must be checked separately by country.

Reported use & evidence

Research profile draft

The supplied Insulin Detemir profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds